Review
doi: 10.1007/BF01556582.
The role of immunotherapy in the management of patients with malignant melanoma
- PMID: 382645
- DOI: 10.1007/BF01556582
Item in Clipboard
Review
The role of immunotherapy in the management of patients with malignant melanoma
World J Surg.
.
No abstract available
Similar articles
-
Corynebacterium parvum versus BCG adjuvant immunotherapy in human malignant melanoma.Cancer. 1983 Jan 1;51(1):57-60. doi: 10.1002/1097-0142(19830101)51:1<57::aid-cncr2820510114>3.0.co;2-v. Cancer. 1983. PMID: 6821809 Clinical Trial.
-
Immunotherapy of malignant melanoma.J Am Acad Dermatol. 1982 Apr;6(4 Pt 1):559-62. doi: 10.1016/s0190-9622(82)80382-4. J Am Acad Dermatol. 1982. PMID: 6176602 Review. No abstract available.
-
[Experience with adjuvant chemoimmunotherapy with DTIC and BCG in malignant melanoma (author's transl)].Z Hautkr. 1982 Feb 15;57(4):294-7. Z Hautkr. 1982. PMID: 7080583 German. No abstract available.
-
DTIC and actinomycin D with and without C. parvum immunotherapy in advanced malignant melanoma.Tumori. 1981 May-Jun;67(3):215-7. doi: 10.1177/030089168106700309. Tumori. 1981. PMID: 7281240 No abstract available.
-
Combined modality therapy of malignant melanoma.World J Surg. 1979 Jul 30;3(3):329-43. doi: 10.1007/BF01556586. World J Surg. 1979. PMID: 382647 Review. No abstract available.
Cited by
-
General surgery-important advances in clinical medicine: cutaneous melanoma.West J Med. 1983 Feb;138(2):244. West J Med. 1983. PMID: 18749293 Free PMC article. No abstract available.
-
Therapeutic vaccination immunomodulation: forming the basis of all cancer immunotherapy.Ther Adv Vaccines Immunother. 2019 Aug 1;7:2515135519862234. doi: 10.1177/2515135519862234. eCollection 2019. Ther Adv Vaccines Immunother. 2019. PMID: 31414074 Free PMC article. Review.
-
Adjuvant BCG immunotherapy for malignant melanoma.Can Med Assoc J. 1984 Oct 1;131(7):744-8. Can Med Assoc J. 1984. PMID: 6383591 Free PMC article. Clinical Trial.